Both activated fibroblasts and macrophages (Qi et al., 2022) can contribute to T cell exclusion from a tumour microenvironment, and there is evidence that CAFs decrease tumour immunosurveillance by CD8-positive T cells (Herrera et al., 2020). The gene discussed is CD8A; the disease is neoplasm.